Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 8 Next >

Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?

September 22, 2022

BioMarin Says One Participant Diagnosed With Leukemia In Late-Stage Hemophilia Gene Therapy Trial

September 12, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

August 24, 2022

BioMarin Receives European Commission's Conditional Marketing Authorization For Gene Therapy Candidate

August 24, 2022

What's Next in Pfizer's M&A Ramp-Up?

August 20, 2022

Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart

August 09, 2022

Expert Ratings for Biomarin Pharmaceutical

August 04, 2022

BioMarin Lifts Annual Guidance On Better Than Expected Q2 Earnings

August 04, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

These eight health-care stocks can keep you invested in the market with less worry

August 02, 2022

7 Undervalued Biotech Stocks to Buy Before They Boom

July 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022

July 13, 2022

Analyst Ratings for Biomarin Pharmaceutical

July 13, 2022

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

June 22, 2022

What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical

June 13, 2022

Is Now the Time to Buy This Risky Stock With Huge Upside Potential?

June 04, 2022

9 Health Care Stocks With Whale Alerts In Today's Session

May 18, 2022

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More

May 09, 2022

BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy

April 28, 2022

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

April 27, 2022

Biomarin Pharmaceutical Earnings Preview

April 26, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

April 25, 2022

10 Biggest Price Target Changes For Monday

April 25, 2022

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More

April 24, 2022

A Bearish Sign Appears On Biomarin Pharmaceutical's Chart

April 21, 2022

7 Potential Biotech Stocks Buyout Targets in 2022

April 21, 2022

Why BioMarin Pharmaceutical Tumbled on Thursday

February 24, 2022

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

February 24, 2022

BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market

February 24, 2022

Recap: Biomarin Pharmaceutical Q4 Earnings

February 23, 2022

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.